These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12599439)

  • 1. [Study on the activities of fluoroquinolones against Staphylococcus aureus and the effect of reserpine on these activities].
    Zhong L; Feng P; Fan X; Lü X; Yu R; Liao F; Lei B
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):91-3. PubMed ID: 12599439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
    Schmitz FJ; Fluit AC; Lückefahr M; Engler B; Hofmann B; Verhoef J; Heinz HP; Hadding U; Jones ME
    J Antimicrob Chemother; 1998 Dec; 42(6):807-10. PubMed ID: 10052906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the resistance of Staphylococcus aureus and the mechanisms of its resistance to fluoroquinolone].
    Lei Y; Gui X; Feng G
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):176-9. PubMed ID: 11798575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.
    Daporta MT; Muñoz Bellido JL; Guirao GY; Hernández MS; García-Rodríguez JA
    Int J Antimicrob Agents; 2004 Aug; 24(2):185-7. PubMed ID: 15288320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.
    Kaatz GW; Moudgal VV; Seo SM
    J Antimicrob Chemother; 2002 Dec; 50(6):833-8. PubMed ID: 12461001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on uptake of fluoroquinolones by Staphylococcus aureus].
    Zhong L; Feng P; Xia P; Lei B; Fan X; Lü X
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):18-20. PubMed ID: 12501602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
    Schmitz FJ; Fluit AC; Milatovic D; Verhoef J; Heinz HP; Brisse S
    J Antimicrob Chemother; 2000 Jul; 46(1):109-13. PubMed ID: 10882698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutant prevention concentrations of fluoroquinolones for Staphylococcus aureus].
    Cui JC; Liu YN; Wang R; Liang BB; Pei F; Zheng ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1863-6. PubMed ID: 15631794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
    Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
    Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.
    Neyfakh AA; Borsch CM; Kaatz GW
    Antimicrob Agents Chemother; 1993 Jan; 37(1):128-9. PubMed ID: 8431010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Markham PN; Westhaus E; Klyachko K; Johnson ME; Neyfakh AA
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2404-8. PubMed ID: 10508015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.
    Metzler K; Hansen GM; Hedlin P; Harding E; Drlica K; Blondeau JM
    Int J Antimicrob Agents; 2004 Aug; 24(2):161-7. PubMed ID: 15288315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
    Strahilevitz J; Robicsek A; Hooper DC
    Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Staphylococcus aureus isolated from colonized hospital personnel.
    Poiată A; Tuchiluş C; Ambăruş A; Teodor A; Teodorescu I; Luca V; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):723-6. PubMed ID: 17571573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the active efflux mechanism in Staphylococcus aureus resistant to quinolone].
    Xu F; Duan DQ; Lin YG
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):403-6. PubMed ID: 15256091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus.
    Piddock LJ; Jin YF; Griggs DJ
    J Antimicrob Chemother; 2001 Mar; 47(3):261-70. PubMed ID: 11222558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.